Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for chronic wound pain in lower extremities
2021-000096-36Phase 2Completed
- Sponsor
- Department of Dermatology, Bispebjerg Hospital
- Start
- Feb 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of botulinum toxin type A in chronic pain and lower extremity ulcer, sponsored by Department of Dermatology, Bispebjerg Hospital. Primary endpoint: Primary: Change in worst pain at rest (VAS) and DN4 questionnaire. Started Feb 2021; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic painlower extremity ulcer
Beyond the preview
Go deeper on 2021-000096-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000096-36.